4th Quarter - Report

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$750,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 21, 2025 $750,000 Replaced
4th Quarter - Amendment Sep 19, 2025 $750,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340B Program; Issues related to affordable prescription drugs; Issues related to health care workforce and staffing; Issues related to health care privacy; Issues related to telehealth authorities; Issues related to hospital price transparency; Issues related to hospital reimbursement; Issues related to nonprofit hospital practices; Issues related to hospital outpatient department payments; Issues related to hospital outpatient department payments; Medicaid Disproportionate Share Hospital payment adjustment program; Issues related to Medicare payments; Issues related to Medicare Advantage payment and prior authorization; Childrens Hospital Graduate Medical Education Program (CHGME); issues related to childrens medical care; issues related to rural health; S. 4352/H.R. 8702, the Seniors Timely Access to Care Act H.R. 2584/S. 2768, the Safety From Violence for Healthcare Employees (SAVE) Act; Expanding Care in the Home Act; H.R. 1770, Equitable Access to Pharmacy Services Act; issues related to Program for All-Inclusive Care for the Elderly (PACE); H.R. 1770, Equitable Access to Pharmacy Services Act; H.R. 3008, the Drug Shortage Prevention Act; H.R. 3810, the Drug Origin Transparency Act; H.R. 3793, the Ensuring Access to Lifesaving Drugs Act; issues related to preventing and mitigating drug shortages; H.R. 2389/S. 1302, the Resident Physician Shortage Reduction Act; H.R. 3263, the Support Faculty and Expand Access to Nursing Act; issues related to prior authorization, unwarranted claim denials, and payment delays; S. 2840, the Bipartisan Primary Care and Health Workforce Expansion Act; H.R. 3561, the PATIENT Act; H.R. 6363, Further Continuing Appropriations and Other Extension Act; H.R. 5378, the Lower Costs, More Transparency Act; Issues related to mental and behavioral health; the limit on Medicare payment days for inpatient psychiatric care; the Institutions for Mental Disease exclusion; issues related to extending programs under the SUPPORT for Patients Communities Act; issues related to cybersecurity; enhanced Advanced Premium Tax Credits

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG New 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2768 (118th), H.R. 2584 (118th), H.R. 3008 (118th), H.R. 8702 (118th), H.R. 3810 (118th), H.R. 3561 (118th), S. 2840 (118th), H.R. 3263 (118th), H.R. 1770 (118th), S. 4352 (118th), S. 1302 (118th), H.R. 3793 (118th), H.R. 5378 (118th), H.R. 2389 (118th), H.R. 6363 (118th)

Medicare/Medicaid MMM

Issues related to affordable prescription drugs; Issues related to telehealth authorities; Issues related to health care workforce and staffing; Medicaid Disproportionate Share Hospital payment adjustment program; Issues related to Medicaid coverage; Issues related to hospital reimbursement; 340B Program; Issues related to hospital price transparency; Issues related to Medicare payments; Issues related to Medicare Advantage payment and prior authorization; issues related to rural health reimbursement, including the Medicare Dependent Hospital and Low Volume Hospital programs; physician reimbursement rates; S. 4352/H.R. 8702, the Seniors Timely Access to Care Act; issues related to Program for All-Inclusive Care for the Elderly (PACE); issues related to improving coordination of care for dual eligibles; issues related to site neutral payments; H.R. 3281, the Transparent PRICE Act; issues related to prior authorization, unwarranted claim denials, and payment delays; the Biologics Price Competition and Innovation Act (BPCIA); H.R. 3561, the PATIENT Act; H.R. 6363, Further Continuing Appropriations and Other Extension Act; H.R. 5378, the Lower Costs, More Transparency Act; PL 118-42/H.R. 4366 - Consolidated Appropriations Act, 2024; PL 118-47/H.R. 2882 - Consolidated Appropriations Act, 2024; Issues related to mental and behavioral health; the limit on Medicare payment days for inpatient psychiatric care; the Institutions for Mental Disease exclusion; issues related to extending programs under the SUPPORT for Patients Communities Act; H.R. 10545, the American Relief Act

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG New 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4366 (118th), H.R. 3281 (118th), S. 4352 (118th), H.R. 2882 (118th), H.R. 5378 (118th), H.R. 8702 (118th), H.R. 10545 (118th), H.R. 6363 (118th), H.R. 3561 (118th)

Pharmacy PHA

340B Program; Issues related to affordable prescription drugs;H.R. 1770, Equitable Access to Pharmacy Services Act; H.R. 3008, the Drug Shortage Prevention Act; H.R. 3810, the Drug Origin Transparency Act; H.R. 3793, the Ensuring Access to Lifesaving Drugs Act; issues related to preventing and mitigating drug shortages;

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG New 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1770 (118th), H.R. 3008 (118th), H.R. 3793 (118th), H.R. 3810 (118th)

Budget/Appropriations BUD

PL 118-42/H.R. 4366 - Consolidated Appropriations Act, 2024; PL 118-47/H.R. 2882 - Consolidated Appropriations Act, 2024

LobbyistCovered position, as disclosed
MARK HAYES 2004-2010:Health Policy Director & 2002-2004:Health Policy Advisor, Sen Finance Cmte; 2001-2002: Sr Health Policy Advsr, Sen. Snowe; 2001:Health Policy Advsr, Sen HELP Cmte; 94-95:Sr Advisor, Sen Sm Bus. Cmte; 94-99:LA 89-90:Staff Asst, Sen. Bond
PETER LEIBOLD —
JOSEPH LUSTIG 2019-2020: Senior Policy Advisor, 2017-2019: Policy Advisor, 2015-2017: Legislative Assistant, 2014-2015: Legislative Correspondent, 2014: Staff Assistant, Rep. Cedric L. Richmond

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2882 (118th), H.R. 4366 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.